Overview of Dr. Keohan
Dr. Mary Keohan is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from St. George's University School of Medicine and has been in practice 28 years. Dr. Keohan accepts several types of health insurance, listed below. She is one of 495 doctors at Memorial Sloan Kettering Cancer Center and one of 62 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. She has more than 90 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1995 - 1998
Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1992 - 1995
St. George's University School of MedicineClass of 1991, MD
Certifications & Licensure
FL State Medical License 2021 - Present
CT State Medical License 2023 - 2025
NJ State Medical License 2020 - 2025
NY State Medical License 1996 - 2025- ABIMMedical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Start of enrollment: 2007 Apr 01
- A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1 Start of enrollment: 2009 Sep 01
- Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 84 citationsPhase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaMark A. Dickson, Michelle R. Mahoney, William D. Tap, Sandra P. D'Angelo, Mary Louise Keohan
Annals of Oncology. 2016-10-01 - 22 citationsA Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal TumorEvan Rosenbaum, Ciara Marie Kelly, Sandra P. D'Angelo, Mark A. Dickson, Mrinal M. Gounder
The Oncologist. 2019-10-01 - 4 citationsTherapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley, Cristina R Antonescu, Rodrigo Gularte-Mérida
Clinical Cancer Research. 2024-02-16
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Georgia Blue Choice HMO
BCBS Georgia BlueChoice Option POS
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOGHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
